Wetter Pharma-Fertigung GmbH & Co. KG (manufacturing bulk products, primary packaging, sterility testing, dot-blot and bioburden testing during production, visual inspection, storage)

The drug is indicated for the treatment of mucopolysaccharidosis type IVA (Morquio A syndrome) in patients of any age.

Dosage form: concentrate for infusion solution

ATC: A16AB12